Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort.

Slides:

Advertisements

Similar presentations

Multifaceted roles for lipids in viral infection Nicholas S. Heaton, Glenn Randall Trends in Microbiology Volume 19, Issue 7, Pages (July 2011)

Advertisements

How do emotion and motivation direct executive control? Luiz Pessoa Trends in Cognitive Sciences Volume 13, Issue 4, Pages (April 2009) DOI: /j.tics

Two views of brain function Marcus E. Raichle Trends in Cognitive Sciences Volume 14, Issue 4, Pages (April 2010) DOI: /j.tics

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Early impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in Singapore children, 2005 through 2010 Koh Cheng Thoon, Chia Yin Chong,

Venezuela: violence, human rights, and health-care realities

Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies Lauren J Ralph, MPH, Sandra I McCoy, PhD, Karen.

Distribution of rotavirus strains and strain-specific effectiveness of the rotavirus vaccine after its introduction: a systematic review and meta-analysis

Volume 16, Issue 9, Pages (September 2015)

The Lancet Public Health

The benefits and harms of breast cancer screening

Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study Alejandra Castanon, MD, Rebecca Landy, PhD,

Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study Dr.

Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period J. Liñares, C. Ardanuy, R. Pallares, A.

Volume 9, Issue 5, Pages (May 2008)

Impact of the emergence of non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia

Pneumococcal Disease Prevention in Children: Issues in the Era of PCVs

Volume 2, Issue 12, Pages e530-e539 (December 2015)

Underestimate of annual malaria imports to Canada – Author reply

Emergence of a serotype 1 Streptococcus pneumoniae lineage colonising healthy children in Portugal in the seven-valent conjugate vaccination era S. Nunes,

When less is more: how many doses of PCV are enough?

Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants:

Guillain-Barré syndrome and H1N1 influenza vaccine in UK children

Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:

Volume 381, Issue 9882, Pages (June 2013)

Ageing in the 21st century

Age-specific relevance of usual blood pressure to vascular mortality

Increase in US medication-error deaths

Constantly high incidence of scarlet fever in Germany

Effectiveness of 23-Valent Polysaccharide Pneumococcal Vaccine and Changes in Invasive Pneumococcal Disease Incidence from 2000 to 2017 in Those Aged.

Emergence of a serotype 1 Streptococcus pneumoniae lineage colonising healthy children in Portugal in the seven-valent conjugate vaccination era S. Nunes,

Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis Manish Pareek, MRCP, John.

Can plagues be predicted, prevented?

The role of vaccination in preventing pneumococcal disease in adults

Rubella vaccination: must not be business as usual

Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis Dr Tinevimbo.

Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study Nabihah Sachedina, MBBS, Prof.

Resuscitation at birth and cognition at 8 years of age: a cohort study

Assessment of herd immunity from human papillomavirus vaccination

What would happen if we stopped vaccination?

Switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10: a defendable approach? Stefanie Desmet, Jan Verhaegen, Marc Van Ranst,

Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes S. Ladhani,

Daniel M. Musher, MD Mayo Clinic Proceedings

Reproductive health for refugees

Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England.

HIV incidence in men who have sex with men in England and Wales 2001–10: a nationwide population study Paul J Birrell, PhD, Prof O Noel Gill, FFPH, Valerie.

Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance.

Effect of pneumococcal conjugate vaccine introduction on childhood pneumonia mortality in Brazil: a retrospective observational study Cynthia Schuck-Paim,

Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study

Streptococcus pneumoniae serotype 1 causing invasive disease among children in Barcelona over a 20-year period (1989–2008) C. Esteva, L. Selva, M.F.

Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study

Volume 388, Issue 10061, Pages (December 2016)

Forecasting the care needs of the older population in England over the next 20 years: estimates from the Population Ageing and Care Simulation (PACSim)

Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national.

Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study Dorothea M C Hill, BA, Jay Lucidarme,

Hidden from history? A brief modern history of the psychiatric “treatment” of lesbian and bisexual women in England Sarah Carr, Helen Spandler The Lancet.

Changes in Streptococcus pneumoniae serotypes causing invasive disease with non- universal vaccination coverage of the seven-valent conjugate vaccine

Low-technology approaches

Prof GJB van Ommen, PhD, E Bakker, PhD, JT den Dunnen, PhD The Lancet

Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage in Fiji: results from four annual cross-sectional carriage surveys

Epidemiology of stroke

Meningococcal serogroup B strain coverage of the multicomponent 4CMenB vaccine with corresponding regional distribution and clinical characteristics in.

Volume 376, Issue 9734, Pages (July 2010)

Genital herpes—how much of a public-health problem?

Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational.

Clinical Microbiology and Infection

Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya John Ojal, PhD, Ulla Griffiths,

Risk factors associated with revision for prosthetic joint infection following knee replacement: an observational cohort study from England and Wales

Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study Gayatri Amirthalingam,

Volume 349, Issue 9062, Pages (May 1997)

Presentation transcript:

Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study Shamez N Ladhani, MRCPCH, Sarah Collins, MPH, Abdelmajid Djennad, PhD, Carmen L Sheppard, PhD, Prof Ray Borrow, PhD, Norman K Fry, PhD, Prof Nicholas J Andrews, PhD, Prof Elizabeth Miller, FRCPath, Mary E Ramsay, FFPHM The Lancet Infectious Diseases Volume 18, Issue 4, Pages 441-451 (April 2018) DOI: 10.1016/S1473-3099(18)30052-5 Copyright © 2018 Elsevier Ltd Terms and Conditions

Figure 1 Corrected trends in IPD incidence in England and Wales for all ages and by age group The epidemiological year runs from July to June. The vertical lines labelled PCV7 and PCV13 denote introduction of the seven-valent and 13-valent pneumococcal conjugate vaccines (PCVs) into the national childhood immunisation programme. PCV7=invasive pneumococcal disease (IPD) due to the serotypes included in the seven-valent PCV. PCV13 only=IPD due to the additional six serotypes included in the 13-valent PCV. Non-PCV13=serotypes responsible for IPD that are not included in the 13-valent PCV. The Lancet Infectious Diseases 2018 18, 441-451DOI: (10.1016/S1473-3099(18)30052-5) Copyright © 2018 Elsevier Ltd Terms and Conditions

Figure 2 Corrected overall and age group-specific trends in invasive pneumococcal disease incidence due to the additional PCV13 serotypes and PCV13-related serotype 6C 7 years after the introduction of PCV13 in England and Wales The epidemiological year runs from July to June. The vertical lines labelled PCV7 and PCV13 denote the introduction of the seven-valent and 13-valent pneumococcal conjugate vaccines into the national childhood immunisation programme. The Lancet Infectious Diseases 2018 18, 441-451DOI: (10.1016/S1473-3099(18)30052-5) Copyright © 2018 Elsevier Ltd Terms and Conditions

Figure 3 Corrected overall and age group-specific trends in invasive pneumococcal disease incidence due to the main replacing serotypes 7 years after the introduction of PCV13 in England and Wales The epidemiological year runs from July to June. The vertical lines labelled PCV7 and PCV13 denote the introduction of the seven-valent and 13-valent pneumococcal conjugate vaccines into the national childhood immunisation programme. The Lancet Infectious Diseases 2018 18, 441-451DOI: (10.1016/S1473-3099(18)30052-5) Copyright © 2018 Elsevier Ltd Terms and Conditions